3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Prostatic Neoplasms
56
Lung Neoplasms
48
Leukemia, Myeloid, Acute
44
Breast Neoplasms
37
Carcinoma, Non-Small-Cell Lung
36
Myelodysplastic Syndromes
27
Pancreatic Neoplasms
24
Leukemia, Lymphocytic, Chronic, B-Cell
24
Multiple Myeloma
23
Colorectal Neoplasms
23
Carcinoma, Renal Cell
22
Neoplasm Metastasis
20
Melanoma
19
Glioblastoma
19
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Ovarian Neoplasms
17
Lymphoma, Large B-Cell, Diffuse
17
Brain Neoplasms
16
Triple Negative Breast Neoplasms
14
Squamous Cell Carcinoma of Head and Neck
12
Carcinoma, Hepatocellular
12
Lymphoma, Mantle-Cell
11
Lymphoma, B-Cell
11
Leukemia, Myelomonocytic, Chronic
11
Fallopian Tube Neoplasms
11
Rectal Neoplasms
10
Myeloproliferative Disorders
10
Lymphoma, Follicular
10
Colonic Neoplasms
10
Hematopoietic and Lymphatic System Neoplasm
9
Interventions
Cisplatin
28
Pemetrexed
24
pembrolizumab
12
Nivolumab
10
Carboplatin
9
atezolizumab
7
Gemcitabine
7
Cyclophosphamide
7
durvalumab
6
Drug Therapy
6
sodium thiosulfate
5
Radiotherapy, Intensity-Modulated
5
tremelimumab
4
aldesleukin
4
Radiotherapy
4
Interleukin-2
4
sargramostim
3
Vinorelbine
3
Platinum
3
Photochemotherapy
3
Ipilimumab
3
Doxorubicin
3
Dihematoporphyrin Ether
3
Chemotherapy, Adjuvant
3
Cerebral Decortication
3
vatalanib
2
regorafenib
2
niraparib
2
lenvatinib
2
cemiplimab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Mesothelioma, Malignant
×
Specimen Handling
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled